Christoph Röllig, Prof. Dr.
Technische Universität Dresden, Medical Faculty Carl Gustav Carus · Universitätsklinikum Carl Gustav Carus · Medizinische Fakultät der TU Dresden, Medizinische Klinik und Poliklinik I
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Christoph Röllig, Prof. Dr. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:47 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT04385290 · Combination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute Myeloid Leukemia (MOSAIC)Technische Universität Dresden · recruiting · Acute Myeloid Leukemia · principal investigator
- N/ANCT03188874 · Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL)Technische Universität Dresden · recruiting · Acute Myeloid Leukemia (AML) · study director
- Ph3NCT02140242 · Comparison Between Two Dose Levels of Daunorubicin and Between One vs. Two Induction Cycles for Adult Patients With AMLTechnische Universität Dresden · completed · Leukemia, Myelocytic, Acute · principal investigator
- Ph2NCT01830361 · Trial to Assess the Efficacy of Midostaurin (PKC412) in Patients With c-KIT or FLT3-ITD Mutated t(8;21) AMLTechnische Universität Dresden · completed · Acute Myeloid Leukemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:47 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 28 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in acute myeloid leukemia.